©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Jun 18, 2015; 7(11): 1562-1571
Published online Jun 18, 2015. doi: 10.4254/wjh.v7.i11.1562
Published online Jun 18, 2015. doi: 10.4254/wjh.v7.i11.1562
Update in management of hepatocellular carcinoma in Eastern population
Kevin Ka Wan Chu, Tan To Cheung, Department of Surgery, the University of Hong Kong, Hong Kong, China
Author contributions: Chu KKW and Cheung TT prepared and wrote the manuscript.
Conflict-of-interest: There is no conflict of interest.
Correspondence to: Tan To Cheung, MBBS (HK), FHKAM (Surgery), FCSHK, FRCS (Edin), Department of Surgery, the University of Hong Kong, 102 Pokfulam Road, Hong Kong, China. tantocheung@hotmail.com
Telephone: +852-22553025 Fax: +852-28165284
Received: November 27, 2014
Peer-review started: November 29, 2014
First decision: January 20, 2015
Revised: February 10, 2015
Accepted: April 10, 2015
Article in press: April 14, 2015
Published online: June 18, 2015
Processing time: 200 Days and 22.6 Hours
Peer-review started: November 29, 2014
First decision: January 20, 2015
Revised: February 10, 2015
Accepted: April 10, 2015
Article in press: April 14, 2015
Published online: June 18, 2015
Processing time: 200 Days and 22.6 Hours
Core Tip
Core tip: Management of hepatocellular carcinoma (HCC) has changed significantly over the past several decades. However, the management of patients has yet to be standardized. As a result of high prevalence of hepatitis B infection in Asia, the experience of the East helped to develop a more aggressive management algorithm. There has been a lot of advancement in terms of diagnosis, management algorithm, staging and treatment methods. This paper will give an update on the management of HCC in the eastern population.